Barclays PLC Genfit S.A. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.09 - $4.25 $46 - $63	-15 Reduced 4.67%	306 $1,000
Q1 2022 May 16, 2022	BUY	$3.14 - $5.04 $1,007 - $1,617	321 New	321 $1,000
Q4 2021 Feb 14, 2022	SELL	$3.01 - $5.65 $6 - $11	-2 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$3.58 - $4.14 $60 - $70	-17 Reduced 89.47%	2 $0
Q1 2021 May 13, 2021	SELL	$4.53 - $6.06 $453 - $606	-100 Reduced 84.03%	19 $0

Q2 2020 Aug 12, 2020	SELL	$5.2 - $22.0 $2,693 - $11,396	-518 Reduced 81.32%	119 $1,000
Q1 2020 May 13, 2020	BUY	$10.95 - $20.76 $6,975 - $13,224	637 New	637 $9,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.